relapsed/refractory haematological malignanciesChimeric Antigen Receptor T-cell (CAR-T) therapy
…(CAR-T) therapy is a complex, novel treatment for patients with relapsed/refractory haematological malignancies. Despite its advancement, research on the supportive care needs…